IO Biotech

IOBT

Market cap $3.45M

Delisted

IOBT was delisted on the 6th of April, 2026.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	NHAS 1 Novo Holdings A/S Hellerup, Denmark	$21M	+$31.7M	+3,277,932	New
2	VC 2 Vivo Capital Palo Alto, California	$19.3M	+$29.1M	+3,015,545	New
3	RCM 3 RA Capital Management Boston, Massachusetts	$11.9M	+$17.9M	+1,857,755	New
4	ACA 4 Avoro Capital Advisors New York	$10.2M	+$19.9M	+2,055,883	New
5	5 Capital World Investors Los Angeles, California	$8.11M	+$11.9M	+1,235,000	New
6	PHS 6 PFM Health Sciences San Francisco, California	$7.74M	+$13.2M	+1,362,144	New
7	SB 7 Samsara BioCapital Palo Alto, California	$7.17M	+$10.8M	+1,120,437	New
8	SCM 8 Soleus Capital Management Greenwich, Connecticut	$4.3M	+$6.5M	+672,734	New
9	9 Vanguard Group Malvern, Pennsylvania	$1.31M	+$1.98M	+205,200	New
10	10 Millennium Management New York	$512K	+$753K	+77,963	New
11	CCM 11 CAAS Capital Management New York	$323K	+$488K	+50,479	New
12	12 Norges Bank Oslo, Norway	$164K	+$241K	+25,000	New
13	13 Squarepoint New York	$98K	+$145K	+14,966	New
14	14 Citadel Advisors Miami, Florida	$86K	+$126K	+13,060	New
15	VF 15 Virtu Financial New York	$83K	+$122K	+12,665	New
16	16 Geode Capital Management Boston, Massachusetts	$73K	+$108K	+11,173	New
17	17 Bank of America Charlotte, North Carolina	$64K	+$96.6K	+10,000	New
18	18 Stifel Financial St. Louis, Missouri	$64K	+$96.6K	+10,000	New
19	19 Morgan Stanley New York	$57K	+$86.5K	+8,958	New
20	TRCT 20 Tower Research Capital (TRC) New York	$10K	+$15.2K	+1,572	New